Entinostat
| CAS No. | 209783-80-2 |
|---|---|
| MDL No. | MFCD08272435 |
| MF | C21H20N4O3 |
| MW | 376.40 |
| InChI Key | INVTYAOGFAGBOE-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Entinostat is a benzamide formed by the condensation of the carboxy group of a pyridin-3-ylmethyl carbamate derivative of p-(aminomethyl)benzoic acid with an amino group of benzene-1,2-diamine. It inhibits histone deacetylase isoforms 1 and 3 (HDAC1 and HDAC3). It functions as an EC 3.5.1.98 histone deacetylase inhibitor, an antineoplastic agent, and an apoptosis inducer. It belongs to pyridines, carbamate esters, substituted anilines, primary amino compounds, and benzamides. It is functionally related to 1,2-phenylenediamine.
| CAS No. | 209783-80-2 |
|---|---|
| Product Name | Entinostat |
Biological Targets
HDAC1·HDAC3·HDAC6·HDAC2·HDAC5·
Associated Conditions
penile cancer·malignant tumor of neck·clear cell renal carcinoma·acute myeloid leukemia·melanoma·
* The information provided here is compiled from public sources and is for reference only.
